New Delhi, India

S M Dileep Kumar

This inventor holds 1 USPTO granted patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: S M Dileep Kumar. Retrieved from https://idiyas.com/inventor/s-m-dileep-kumar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of S M Dileep Kumar

Introduction

S M Dileep Kumar is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of atorvastatin calcium.

Latest Patents

His most recent patent is titled "Process for the production of amorphous atorvastatin calcium." This innovative process involves dissolving crystalline atorvastatin calcium in a non-hydroxylic solvent, adding a non-polar hydrocarbon anti-solvent, and subsequently removing the solvent by filtration to yield amorphous atorvastatin calcium. This patent showcases his expertise in pharmaceutical formulations and processes.

Career Highlights

S M Dileep Kumar is currently employed at Ranbaxy Laboratories, Inc., where he continues to work on innovative pharmaceutical solutions. His role at the company allows him to apply his knowledge and skills in a practical setting, contributing to advancements in the industry.

Collaborations

He has collaborated with notable colleagues such as Yatendra Kumar and Rajesh Kumar Thaper. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

S M Dileep Kumar's contributions to the field of pharmaceuticals, particularly through his patent on atorvastatin calcium, highlight his role as an influential inventor. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…